LIVE

MCK

McKesson Corporation

MCK

NYSE·Healthcare·Medical - Distribution·Mkt cap $89.9B

$786.30

▲ +2.37%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$637.00 - $999.00

P/E

20.44

Fwd P/E

17.83

Beta

0.32

Div Yield

0.43%

Avg Vol

1.1M

Shares Out

120.2M

Mkt Cap

$89.9B

Price action

Price chart

Up 8.9% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Extensive nationwide distribution network
  • Comprehensive healthcare technology platforms
  • Strong relationships with pharmaceutical manufacturers
  • Diversified revenue streams across healthcare segments
▼

Bear Case

2 risks

  • Low volatility (beta 0.3).
  • Premium valuation to Healthcare Distribution peers

Growth

Stable outlook

Healthcare digitalization

Value

Premium valuation to Healthcare Distribution peers

Momentum

Weak

-13.1% over 3m

Quality

Thin

Excellent business quality

Dividend

Token

0.43% yield

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 5, 2026

“
Q2 26 RECAP

MAY 7, 2026

Reported EPS of $11.69 vs $11.56 consensus (+1.1% surprise). Revenue of $96.3B vs $101.3B expected (-5.0%).

EPS beat +1.1%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+1.1%

Next: Aug 5, 2026

Revenue trend · last 8Q

—

—

+18%

+19%

+23%

+10%

+11%

+6%

Q1 24

Q2 24

Q3 24

Q4 25

Q1 25

Q2 25

Q3 25

Q4 26

$79.3B

$93.7B

$95.3B

$90.8B

$97.8B

$103.2B

$106.2B

$96.3B

Margins · last 8Q

Gross

4.2%

Operating

2.3%

Profit

1.8%

View full earnings history →

Wall Street consensus

9 analysts · 78% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

7

78%

Hold

2

22%

Sell

0%

Median Price Target

$962.50

▲ +22.4% vs $786.30

Low $875.00
Median $962.50
High $1,050.00

Latest: Citi · May 14, 2026

2 analysts covering

View full analyst page →

vs Industry

How MCK stacks vs Medical - Distribution

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.